LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 13

Search options

  1. Book ; Thesis: Die Rolle der Proteine p66shc und CyclophilinD für die pulmonalvaskuläre Hypoxiereaktion

    Gierhardt, Mareike

    (Edition Scientifique)

    2017  

    Title variant CypD, p66shc und pulmonale Hypoxie
    Author's details Mareike Gierhardt
    Series title Edition Scientifique
    Keywords Doktorarbeit ; Uni ; Wissenschaft
    Subject code 630
    Language German
    Size 224 Seiten, 21 cm x 14.6 cm, 310 g
    Edition 1. Auflage
    Publisher VVB Laufersweiler Verlag
    Publishing place Gießen
    Publishing country Germany
    Document type Book ; Thesis
    Thesis / German Habilitation thesis Dissertation, Universität Gießen, 2017
    Note Zusammenfassung in deutscher und englischer Sprache
    HBZ-ID HT019462991
    ISBN 978-3-8359-6595-9 ; 3-8359-6595-6
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  2. Book: Die Rolle der Proteine p66shc und CyclophilinD für die pulmonalvaskuläre Hypoxiereaktion

    Gierhardt, Mareike

    (Edition Scientifique)

    2017  

    Abstract: Die hypoxische pulmonale Vasokonstriktion (HPV) ist ein lebenswichtiger physiologischer Mechanismus, welcher die Perfusion der Lunge an den aktuellen Sauerstoffpartialdruck in den Alveolen anpasst. Während dieser Vorgang bei lokalem Auftreten vor einer ... ...

    Series title Edition Scientifique
    Abstract Die hypoxische pulmonale Vasokonstriktion (HPV) ist ein lebenswichtiger physiologischer Mechanismus, welcher die Perfusion der Lunge an den aktuellen Sauerstoffpartialdruck in den Alveolen anpasst. Während dieser Vorgang bei lokalem Auftreten vor einer lebensbedrohlichen Sauerstoffarmut des Blutes schützen kann, führt er bei einem Auftreten in der gesamten Lunge zu einer Einengungen des Lungengefäßbettes, und somit zu einer Erhöhung des pulmonalarteriellen Druckes. Unter chronischen Bedingung...
    Keywords Doktorarbeit ; Uni ; Wissenschaft
    Language German
    Size 230 p.
    Publisher VVB Laufersweiler Verlag
    Document type Book
    Note Hochschulschriften Medizin
    Format 146 x 210
    ISBN 9783835965959 ; 3835965956
    Database PDA

    Kategorien

  3. Book: Die Rolle der Proteine p66shc und CyclophilinD für die pulmonalvaskuläre Hypoxiereaktion

    Gierhardt, Mareike

    (édition scientifique)

    2017  

    Title variant CypD, p66shc und pulmonale Hypoxie
    Institution VVB LAUFERSWEILER Verlag
    Author's details von Mareike Gierhardt
    Series title édition scientifique
    Language German
    Size 224 Seiten, Diagramme, 21 cm x 14.6 cm, 310 g
    Edition 1. Auflage
    Publisher VVB Laufersweiler Verlag
    Publishing place Gießen, Lahn
    Document type Book
    ISBN 3835965956 ; 9783835965959
    Database Special collection on veterinary medicine and general parasitology

    More links

    Kategorien

  4. Article ; Online: The Role of the Redox Enzyme p66Shc in Biological Aging of the Lung.

    Castro, Claudia F Garcia / Nardiello, Claudio / Hadzic, Stefan / Kojonazarov, Baktybek / Kraut, Simone / Gierhardt, Mareike / Schäffer, Julia / Bednorz, Mariola / Quanz, Karin / Heger, Jacqueline / Korfei, Martina / Wilhelm, Jochen / Hecker, Matthias / Bartkuhn, Marek / Arnhold, Stefan / Guenther, Andreas / Seeger, Werner / Schulz, Rainer / Weissmann, Norbert /
    Sommer, Natascha / Pak, Oleg

    Aging and disease

    2024  Volume 15, Issue 2, Page(s) 911–926

    Abstract: The mitochondrial adaptor protein p66Shc has been suggested to control life span in mice via the release of hydrogen peroxide. However, the role of p66Shc in lung aging remains unsolved. Thus, we investigated the effects of ... ...

    Abstract The mitochondrial adaptor protein p66Shc has been suggested to control life span in mice via the release of hydrogen peroxide. However, the role of p66Shc in lung aging remains unsolved. Thus, we investigated the effects of p66Shc
    MeSH term(s) Animals ; Mice ; Src Homology 2 Domain-Containing, Transforming Protein 1/genetics ; Shc Signaling Adaptor Proteins/genetics ; X-Ray Microtomography ; Aging/genetics ; Lung/diagnostic imaging ; Oxidation-Reduction
    Chemical Substances SHC1 protein, human ; Src Homology 2 Domain-Containing, Transforming Protein 1 ; Shc Signaling Adaptor Proteins
    Language English
    Publishing date 2024-04-01
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2625789-0
    ISSN 2152-5250 ; 2152-5250
    ISSN (online) 2152-5250
    ISSN 2152-5250
    DOI 10.14336/AD.2023.0715
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Impairment of hypoxic pulmonary vasoconstriction in acute respiratory distress syndrome.

    Gierhardt, Mareike / Pak, Oleg / Walmrath, Dieter / Seeger, Werner / Grimminger, Friedrich / Ghofrani, Hossein A / Weissmann, Norbert / Hecker, Matthias / Sommer, Natascha

    European respiratory review : an official journal of the European Respiratory Society

    2021  Volume 30, Issue 161

    Abstract: Acute respiratory distress syndrome (ARDS) is a serious complication of severe systemic or local pulmonary inflammation, such as caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. ARDS is characterised by diffuse alveolar ... ...

    Abstract Acute respiratory distress syndrome (ARDS) is a serious complication of severe systemic or local pulmonary inflammation, such as caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. ARDS is characterised by diffuse alveolar damage that leads to protein-rich pulmonary oedema, local alveolar hypoventilation and atelectasis. Inadequate perfusion of these areas is the main cause of hypoxaemia in ARDS. High perfusion in relation to ventilation (V/Q<1) and shunting (V/Q=0) is not only caused by impaired hypoxic pulmonary vasoconstriction but also redistribution of perfusion from obstructed lung vessels. Rebalancing the pulmonary vascular tone is a therapeutic challenge. Previous clinical trials on inhaled vasodilators (nitric oxide and prostacyclin) to enhance perfusion to high V/Q areas showed beneficial effects on hypoxaemia but not on mortality. However, specific patient populations with pulmonary hypertension may profit from treatment with inhaled vasodilators. Novel treatment targets to decrease perfusion in low V/Q areas include epoxyeicosatrienoic acids and specific leukotriene receptors. Still, lung protective ventilation and prone positioning are the best available standard of care. This review focuses on disturbed perfusion in ARDS and aims to provide basic scientists and clinicians with an overview of the vascular alterations and mechanisms of V/Q mismatch, current therapeutic strategies, and experimental approaches.
    MeSH term(s) COVID-19/complications ; Humans ; Hypoxia ; Lung/physiopathology ; Respiratory Distress Syndrome/diagnosis ; Respiratory Distress Syndrome/etiology ; Respiratory Distress Syndrome/therapy ; SARS-CoV-2 ; Vasoconstriction
    Language English
    Publishing date 2021-09-15
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 1077620-5
    ISSN 1600-0617 ; 0905-9180
    ISSN (online) 1600-0617
    ISSN 0905-9180
    DOI 10.1183/16000617.0059-2021
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Decreased plasma levels of the brain-derived neurotrophic factor correlate with right heart congestion in pulmonary arterial hypertension.

    Schäfer, Katharina / Tello, Khodr / Pak, Oleg / Richter, Manuel / Gierhardt, Mareike / Kwapiszewska, Grazyna / Veith, Christine / Fink, Ludger / Gall, Henning / Hecker, Matthias / Kojonazarov, Baktybek / Kraut, Simone / Lo, Kevin / Wilhelm, Jochen / Grimminger, Friedrich / Seeger, Werner / Schermuly, Ralph T / Ghofrani, Hossein A / Zahner, Daniel /
    Gerstberger, Rüdiger / Weissmann, Norbert / Sydykov, Akylbek / Sommer, Natascha

    ERJ open research

    2023  Volume 9, Issue 2

    Abstract: Background: The brain-derived neurotrophic factor (BDNF) may promote development of pulmonary hypertension and right ventricular (RV) failure. However, BDNF plasma levels were decreased in patients with left ventricular (LV) failure. Therefore, we ... ...

    Abstract Background: The brain-derived neurotrophic factor (BDNF) may promote development of pulmonary hypertension and right ventricular (RV) failure. However, BDNF plasma levels were decreased in patients with left ventricular (LV) failure. Therefore, we investigated BDNF plasma levels in pulmonary hypertension patients and the role of BDNF in mouse models of pulmonary hypertension and isolated RV failure.
    Methods: BDNF plasma levels were correlated to pulmonary hypertension in two patient cohorts, including either post- and pre-capillary pulmonary hypertension patients (first cohort) or only pre-capillary pulmonary hypertension patients (second cohort). In the second cohort, RV dimensions and load-independent function were determined by imaging and pressure-volume catheter measurements, respectively. For induction of isolated RV pressure overload, heterozygous
    Results: Plasma BDNF levels were decreased in patients with pulmonary hypertension. Following adjustment for covariables, BDNF levels negatively correlated in both cohorts with central venous pressure. In the second cohort, BDNF levels additionally negatively correlated with RV dilatation. In animal models, BDNF downregulation attenuated RV dilatation in
    Conclusions: Similar to LV failure, circulating levels of BDNF were decreased in pulmonary hypertension patients, and low BDNF levels were associated with right heart congestion. Decreased BDNF levels did not worsen RV dilatation in animal models, and thus, may be the consequence, but not the cause of RV dilatation.
    Language English
    Publishing date 2023-03-06
    Publishing country England
    Document type Journal Article
    ZDB-ID 2827830-6
    ISSN 2312-0541
    ISSN 2312-0541
    DOI 10.1183/23120541.00230-2022
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Decreased plasma levels of the brain-derived neurotrophic factor correlate with right heart congestion in pulmonary arterial hypertension

    Katharina Schäfer / Khodr Tello / Oleg Pak / Manuel Richter / Mareike Gierhardt / Grazyna Kwapiszewska / Christine Veith / Ludger Fink / Henning Gall / Matthias Hecker / Baktybek Kojonazarov / Simone Kraut / Kevin Lo / Jochen Wilhelm / Friedrich Grimminger / Werner Seeger / Ralph T. Schermuly / Hossein A. Ghofrani / Daniel Zahner /
    Rüdiger Gerstberger / Norbert Weissmann / Akylbek Sydykov / Natascha Sommer

    ERJ Open Research, Vol 9, Iss

    2023  Volume 2

    Abstract: Background The brain-derived neurotrophic factor (BDNF) may promote development of pulmonary hypertension and right ventricular (RV) failure. However, BDNF plasma levels were decreased in patients with left ventricular (LV) failure. Therefore, we ... ...

    Abstract Background The brain-derived neurotrophic factor (BDNF) may promote development of pulmonary hypertension and right ventricular (RV) failure. However, BDNF plasma levels were decreased in patients with left ventricular (LV) failure. Therefore, we investigated BDNF plasma levels in pulmonary hypertension patients and the role of BDNF in mouse models of pulmonary hypertension and isolated RV failure. Methods BDNF plasma levels were correlated to pulmonary hypertension in two patient cohorts, including either post- and pre-capillary pulmonary hypertension patients (first cohort) or only pre-capillary pulmonary hypertension patients (second cohort). In the second cohort, RV dimensions and load-independent function were determined by imaging and pressure–volume catheter measurements, respectively. For induction of isolated RV pressure overload, heterozygous Bdnf knockout (Bdnf+/−) mice were subjected to pulmonary arterial banding (PAB). For induction of pulmonary hypertension, mice with inducible knockout of BDNF in smooth muscle cells (Bdnf/Smmhc knockout) were exposed to chronic hypoxia. Results Plasma BDNF levels were decreased in patients with pulmonary hypertension. Following adjustment for covariables, BDNF levels negatively correlated in both cohorts with central venous pressure. In the second cohort, BDNF levels additionally negatively correlated with RV dilatation. In animal models, BDNF downregulation attenuated RV dilatation in Bdnf+/−mice after PAB or hypoxic Bdnf/Smmhc knockout mice, although they developed pulmonary hypertension to a similar extent. Conclusions Similar to LV failure, circulating levels of BDNF were decreased in pulmonary hypertension patients, and low BDNF levels were associated with right heart congestion. Decreased BDNF levels did not worsen RV dilatation in animal models, and thus, may be the consequence, but not the cause of RV dilatation.
    Keywords Medicine ; R
    Subject code 610 ; 616
    Language English
    Publishing date 2023-03-01T00:00:00Z
    Publisher European Respiratory Society
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  8. Article ; Online: Amelioration of elastase-induced lung emphysema and reversal of pulmonary hypertension by pharmacological iNOS inhibition in mice.

    Fysikopoulos, Athanasios / Seimetz, Michael / Hadzic, Stefan / Knoepp, Fenja / Wu, Cheng-Yu / Malkmus, Kathrin / Wilhelm, Jochen / Pichl, Alexandra / Bednorz, Mariola / Tadele Roxlau, Elsa / Ghofrani, Hossein A / Sommer, Natascha / Gierhardt, Mareike / Schermuly, Ralph T / Seeger, Werner / Grimminger, Friedrich / Weissmann, Norbert / Kraut, Simone

    British journal of pharmacology

    2020  Volume 178, Issue 1, Page(s) 152–171

    Abstract: Background and purpose: Chronic obstructive pulmonary disease, encompassing chronic airway obstruction and lung emphysema, is a major worldwide health problem and a severe socio-economic burden. Evidence previously provided by our group has shown that ... ...

    Abstract Background and purpose: Chronic obstructive pulmonary disease, encompassing chronic airway obstruction and lung emphysema, is a major worldwide health problem and a severe socio-economic burden. Evidence previously provided by our group has shown that inhibition of inducible NOS (iNOS) prevents development of mild emphysema in a mouse model of chronic tobacco smoke exposure and can even trigger lung regeneration. Moreover, we could demonstrate that pulmonary hypertension is not only abolished in cigarette smoke-exposed iNOS
    Experimental approach: We have established a mouse model using a single dose of porcine pancreatic elastase or saline, intratracheally instilled in C57BL/6J mice. Emphysema, as well as pulmonary hypertension development was determined by both structural and functional measurements.
    Key results: Our data revealed that (i) emphysema is fully established after 21 days, with the same degree of emphysema after 21 and 28 days post instillation, (ii) emphysema is stable for at least 12 weeks and (iii) pulmonary hypertension is evident, in contrast to smoke models, only after emphysema development. Oral treatment with the iNOS inhibitor N(6)-(1-iminoethyl)-l-lysine (L-NIL) was started after emphysema establishment and continued for 12 weeks. This resulted in significant lung regeneration, evident in the improvement of emphysema and reversal of pulmonary hypertension.
    Conclusion and implications: Our data indicate that iNOS is a potential new therapeutic target to treat severe emphysema and associated pulmonary hypertension.
    Linked articles: This article is part of a themed issue on Risk factors, comorbidities, and comedications in cardioprotection. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v178.1/issuetoc.
    MeSH term(s) Animals ; Disease Models, Animal ; Emphysema ; Hypertension, Pulmonary/chemically induced ; Hypertension, Pulmonary/drug therapy ; Lung ; Mice ; Mice, Inbred C57BL ; Pancreatic Elastase ; Smoke/adverse effects ; Swine
    Chemical Substances Smoke ; Pancreatic Elastase (EC 3.4.21.36)
    Language English
    Publishing date 2020-04-28
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80081-8
    ISSN 1476-5381 ; 0007-1188
    ISSN (online) 1476-5381
    ISSN 0007-1188
    DOI 10.1111/bph.15057
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Genetic deletion of p66shc and/or cyclophilin D results in decreased pulmonary vascular tone.

    Gierhardt, Mareike / Pak, Oleg / Sydykov, Akylbek / Kraut, Simone / Schäffer, Julia / Garcia, Claudia / Veith, Christine / Zeidan, Esraa M / Brosien, Monika / Quanz, Karin / Esfandiary, Azadeh / Saraji, Alireza / Hadzic, Stefan / Kojonazarov, Baktybek / Wilhelm, Jochen / Ghofrani, Hossein A / Schermuly, Ralph T / Seeger, Werner / Grimminger, Friedrich /
    Herden, Christiane / Schulz, Rainer / Weissmann, Norbert / Heger, Jacqueline / Sommer, Natascha

    Cardiovascular research

    2020  Volume 118, Issue 1, Page(s) 305–315

    Abstract: Aims: The pulmonary vascular tone and hypoxia-induced alterations of the pulmonary vasculature may be regulated by the mitochondrial membrane permeability transition pore (mPTP) that controls mitochondrial calcium load and apoptosis. We thus ... ...

    Abstract Aims: The pulmonary vascular tone and hypoxia-induced alterations of the pulmonary vasculature may be regulated by the mitochondrial membrane permeability transition pore (mPTP) that controls mitochondrial calcium load and apoptosis. We thus investigated, if the mitochondrial proteins p66shc and cyclophilin D (CypD) that regulate mPTP opening affect the pulmonary vascular tone.
    Methods and results: Mice deficient for p66shc (p66shc-/-), CypD (CypD-/-), or both proteins (p66shc/CypD-/-) exhibited decreased pulmonary vascular resistance (PVR) compared to wild-type mice determined in isolated lungs and in vivo. In contrast, systemic arterial pressure was only lower in CypD-/- mice. As cardiac function and pulmonary vascular remodelling did not differ between genotypes, we determined alterations of vascular contractility in isolated lungs and calcium handling in pulmonary arterial smooth muscle cells (PASMC) as underlying reason for decreased PVR. Potassium chloride (KCl)-induced pulmonary vasoconstriction and KCl-induced cytosolic calcium increase determined by Fura-2 were attenuated in all gene-deficient mice. In contrast, KCl-induced mitochondrial calcium increase determined by the genetically encoded Mito-Car-GECO and calcium retention capacity were increased only in CypD-/- and p66shc/CypD-/- mitochondria indicating that decreased mPTP opening affected KCl-induced intracellular calcium peaks in these cells. All mouse strains showed a similar pulmonary vascular response to chronic hypoxia, while acute hypoxic pulmonary vasoconstriction was decreased in gene-deficient mice indicating that CypD and p66shc regulate vascular contractility but not remodelling.
    Conclusions: We conclude that p66shc specifically regulates the pulmonary vascular tone, while CypD also affects systemic pressure. However, only CypD acts via regulation of mPTP opening and mitochondrial calcium regulation.
    MeSH term(s) Animals ; Arterial Pressure ; Calcium/metabolism ; Calcium Signaling ; Cell Proliferation ; Cells, Cultured ; Peptidyl-Prolyl Isomerase F/deficiency ; Peptidyl-Prolyl Isomerase F/genetics ; Disease Models, Animal ; Gene Deletion ; Hypertension, Pulmonary/enzymology ; Hypertension, Pulmonary/etiology ; Hypertension, Pulmonary/genetics ; Hypertension, Pulmonary/physiopathology ; Hypoxia/complications ; Mice, Inbred C57BL ; Mice, Knockout ; Mitochondria/enzymology ; Mitochondria/genetics ; Mitochondrial Permeability Transition Pore/metabolism ; Pulmonary Artery/enzymology ; Pulmonary Artery/physiopathology ; Src Homology 2 Domain-Containing, Transforming Protein 1/deficiency ; Src Homology 2 Domain-Containing, Transforming Protein 1/genetics ; Vascular Remodeling ; Vascular Resistance ; Vasoconstriction ; Mice
    Chemical Substances Peptidyl-Prolyl Isomerase F ; Mitochondrial Permeability Transition Pore ; Shc1 protein, mouse ; Src Homology 2 Domain-Containing, Transforming Protein 1 ; Calcium (SY7Q814VUP)
    Language English
    Publishing date 2020-10-28
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 80340-6
    ISSN 1755-3245 ; 0008-6363
    ISSN (online) 1755-3245
    ISSN 0008-6363
    DOI 10.1093/cvr/cvaa310
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Impact of the mitochondria-targeted antioxidant MitoQ on hypoxia-induced pulmonary hypertension.

    Pak, Oleg / Scheibe, Susan / Esfandiary, Azadeh / Gierhardt, Mareike / Sydykov, Akylbek / Logan, Angela / Fysikopoulos, Athanasios / Veit, Florian / Hecker, Matthias / Kroschel, Florian / Quanz, Karin / Erb, Alexandra / Schäfer, Katharina / Fassbinder, Mirja / Alebrahimdehkordi, Nasim / Ghofrani, Hossein A / Schermuly, Ralph T / Brandes, Ralf P / Seeger, Werner /
    Murphy, Michael P / Weissmann, Norbert / Sommer, Natascha

    The European respiratory journal

    2018  

    Abstract: Increased mitochondrial reactive oxygen species (ROS), particularly superoxide have been suggested to mediate hypoxic pulmonary vasoconstriction (HPV), chronic hypoxia-induced pulmonary hypertension (PH) and right ventricular (RV) remodelling.We ... ...

    Abstract Increased mitochondrial reactive oxygen species (ROS), particularly superoxide have been suggested to mediate hypoxic pulmonary vasoconstriction (HPV), chronic hypoxia-induced pulmonary hypertension (PH) and right ventricular (RV) remodelling.We determined ROS in acute, chronic hypoxia and investigated the effect of the mitochondria-targeted antioxidant MitoQ under these conditions.The effect of MitoQ or its inactive carrier substance, decyltriphenylphosphonium (TPP
    Language English
    Publishing date 2018-02-01
    Publishing country England
    Document type Journal Article
    ZDB-ID 639359-7
    ISSN 1399-3003 ; 0903-1936
    ISSN (online) 1399-3003
    ISSN 0903-1936
    DOI 10.1183/13993003.01024-2017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top